Anticancer activity of crude extracts and active fractions obtained from Piper regnellii (Miq.) C. DC. var. regnellii

Orientadores: João Ernesto de Carvalho, Mary Ann FoglioDissertação (mestrado) - Universidade Estadual de Campinas, Instituto de BiologiaResumo: O câncer é um conjunto de doenças que atinge milhões de pessoas, sendo a segunda causa de morte da população mundial. Caracteriza-se pelo desenvolvimento de células instáveis que passam a não responder aos estímulos internos e externos que controlam a proliferação, diferenciação e morte celular. Apesar da grande quantidade de estudos relacionados ao gênero Piper e suas espécies, não há descrição sobre a atividade antiproliferativa in vitro e antitumoral in vivo da espécie P. regnellii (Miq.) C. DC. var. regnellii. O presente estudo avaliou a atividade antiproliferativa in vitro desta espécie, coletada em três épocas diferentes: junho e outubro de 2008 e fevereiro de 2009. Dentre as coletas realizadas, o extrato bruto diclorometânico de junho e suas frações de média polaridade apresentaram atividade citotóxica in vitro com boa correlação entre concentração e efeito e também seletividade para as linhagens hormônio-dependentes de ovário (OVCAR-3) e mama (MCF7), bem como para as linhagens de melanoma (UACC- 62) e próstata (PC-3). De acordo com os nossos estudos, uma das substâncias responsáveis por esta atividade é uma neolignana denominada eupomatenóide-5. Os efeitos observados in vitro pela fração rica em lignanas foram comprovados em modelo in vivo de tumor sólido de Ehrlich. Além disso, o extrato bruto diclorometânico de P. regnellii reduziu o edema de pata produzido por carragenina sugerindo uma correlação entre câncer e inflamação. Este é o primeiro trabalho que relata o efeito antiproliferativo e antiinflamatório de P. regnellii e os resultados obtidos incentivam a continuação dos estudos visando a elucidação do mecanismo de ação e identificando outros princípios ativos que, em sinergismo com o composto eupomatenóide-5, potencializem a atividade de P. regnellii.Abstract: Cancer is a pool of many diseases diagnosed in thousands of people all over the world and represents the second major cause of death worldwide. The loss of normal cell growth control is the main event in the development of cancer and includes specific steps known as cell proliferation, differentiation and apoptosis. Despite numerous studies related to Piper genus, there is no description of any antiproliferative (in vitro) or antitumoral activity (in vivo) of Piper regnellii (Miq.) C. DC. var. regnellii. The present study evaluated the antiproliferative activity of this species, collected in three different periods: June and October, 2008 and February 2009. Among the plants evaluated, the medium polarity fractions obtained from the dichloromethanic crude extract of the plants collected in June presented concentration-effect correlation and also selectivity towards hormonedependent ovary (OVCAR-3) and breast (MCF7) cell lines, as well as melanoma (UACC- 62) and prostate (PC-3). According to our studies, one of the compounds responsible for this activity is classified as eupomatenoid-5, that is a neolignan. Effects observed in vitro for the lignans enriched fractions were confirmed through the Ehrlich solid tumor model in mice. In addition, preliminary results with dichloromethane crude extract of P. regnellii in anti-inflammatory experimental model of paw edema induced by carrageenan suggest the connection between cancer and inflammation. The present study represents the first report of both antiproliferative and anti-inflammatory promising activities of this species indicating the benefits of further studies in the search of more purified compounds and active principles that in synergism with eupomatenoid-5 can potentiate anticancer activity's result, as well as their mechanisms of action.MestradoBiologia CelularMestre em Biologia Celular e Estrutura

Antiproliferative Effect Of Synadenium Grantii Hook F. Stems (euphorbiaceae) And A Rare Phorbol Diterpene Ester

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Synadenium grantii is frequently used for the treatment of various diseases such as allergies, gastric disorders, and especially cancer. The aim of this study was to evaluate the possible antiproliferative potential of the methanol extract, fractions, and pure compounds from the stems of S grantii. Phytochemical analysis was carried out by conventional chromatographic techniques, and the antiproliferative activity was analyzed using the sulforhodamine B assay and an MTT-based assay. Nonpolar fraction and its subfractions from the stems of S grantii exhibited promising cytostatic effect against several human tumor cell lines (glioma, breast, kidney, and lung), with total grown inhibition values ranging from 0.37 to 2.9 g/mL. One of the active principles of this plant was identified as a rare phorbol diterpene ester, denoted as 3,4,12,13-tetraacetylphorbol-20-phenylacetate. This compound demonstrated antiproliferative activity against glioma, kidney, lung, and triple-negative breast cancer cell lines. These results demonstrate that S grantii stems produce active principles with relevant antiproliferative potential.356666671Network Ribecancer (CYTED/CNPq) [212RT 0464]National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq)ProPPEC/UNIVALIConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

Healing Potential of Propolis in Skin Wounds Evidenced by Clinical Studies

Propolis has been used since ancient times for the treatment of skin diseases and, currently, its pharmacological potential for healing and repairing various types of wounds is widely cited in the literature. The healing properties of propolis are mainly attributed to its composition which is rich in phenolic compounds, and propolis has aroused the interest of the pharmaceutical industry as a low-cost product as compared with other treatments and medications; however, most of the published data refer to its effects in vitro and in vivo and, so far, few clinical studies have been carried out proving its therapeutic efficacy. In this article, we aimed to review clinical trail data published in Portuguese, Spanish, and English, in Scielo, PubMed, Google Scholar, Medline, and Lilacs between 1990 and 2021 on the clinical use of propolis for skin ulcers. The potential of propolis as an alternative healing treatment for skin wounds such as diabetic, venous, and surgical wounds, as well as wounds caused by burns, etc., is mainly due to its evidenced properties such as antimicrobial, anti-inflammatory, analgesic, and angiogenesis promoter effects. However, there is a need to standardize the type of administration and the concentration of propolis for each type of wound. Furthermore, further clinical studies are essential to add information about propolis safety and for obtaining the best possible therapeutic benefits from its use

Different Cell Death Responses Induced By Eupomatenoid-5 In Mcf-7 And 786-0 Tumor Cell Lines

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Natural products remain an important source of new drugs, including anticancer drugs. Recently, our group reported the anticancer activity of eupomatenoid-5 (eup-5), a neolignan isolated from Piper regnellii (Miq.) C. DC. var. regnellii leaves. In vitro studies demonstrated that MCF-7 (breast) and 786-0 (kidney) were among the cancer cell lines most sensitive to eup-5 treatment. The current results demonstrate that mitochondrial membrane depolarization and generation of reactive oxygen species are implicated in eup-5-mediated cytotoxic effects on these cancer cells lines. In MCF-7 cells, eup-5 led to phosphatidylserine externalization and caspase activation, whereas the same did not occur in 786-0 cells. Scanning electron microscopy revealed a reduction of microvilli density, as well as cell morphology alterations. Moreover, treated MCF-7 cells exhibited well-characterized apoptosis alterations, while treated 786-0 cells exhibited characteristics of programmed necroptosis process. These findings support the possibility that different mechanisms may be targeted by eup-5 in cell death response. (C) 2015 Elsevier Ltd. All rights reserved.29510261033Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)National Cancer Institute-Frederick, MA, USAFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)FAPESP [2010/50232-7

Biflavonoids: Preliminary Reports on Their Role in Prostate and Breast Cancer Therapy

Dimeric flavonoids, also called biflavonoids, are bioactive compounds that exhibit various activities described in the literature, including antibacterial, antifungal, antiviral, anti-inflammatory, analgesic, antioxidant, vasorelaxant, and anticancer properties. This work focuses on the anticancer action of naturally occurring dimeric flavonoids against prostate and breast cancer, as well as on the mechanisms of action involved in their activity and presents the most current information on this subject in the literature. In the present review, we summarize the latest findings on the antiproliferative activity of 33 dimeric flavonoid-based compounds selected from recently published studies. The tests conducted were in silico and in vitro and demonstrated the cytotoxic activity potential of biflavonoids against prostate and breast tumor cells. Biflavonoids were capable of interfering with the migration and replication of cancer cells and their mechanism of action is related to cell death pathways, especially apoptosis, necrosis, and ferroptosis. These compounds decreased mitochondrial membrane potential and significantly increased intracellular levels of reactive oxygen species (ROS). Additionally, they significantly upregulated the expression of p21, Bax, and cleaved caspase-3, while downregulating Bcl-2 and caspase-3 levels, indicating their cell death mechanism of action is through the Bcl-2/Bax/cleaved caspase-3 pathway and cell cycle arrest. The biflavonoids here related have shown promising anticancer activity and are considered potential drug candidates for prostate and breast cancer treatment

Pharmacological and Therapeutic Potential of Myristicin: A Literature Review

Natural products have been used by humanity for many centuries to treat various illnesses and with the advancement of technology, it became possible to isolate the substances responsible for the beneficial effects of these products, as well as to understand their mechanisms. In this context, myristicin, a substance of natural origin, has shown several promising activities in a large number of in vitro and in vivo studies carried out. This molecule is found in plants such as nutmeg, parsley, carrots, peppers, and several species endemic to the Asian continent. The purpose of this review article is to discuss data published in the last 10 years at Pubmed, Lilacs and Scielo databases, reporting beneficial effects, toxicity and promising data of myristicin for its future use in medicine. From 94 articles found in the literature, 68 were included. Exclusion criteria took into account articles whose tested extracts did not have myristicin as one of the major compounds

ComposiÇço FarmacÊutica Contendo Eupomatenàide-5 ExtraÍdo De Piper Regnelli E Seu Uso Em ComposiÇÕes Medicamentosas Destinadas Para O Tratamento De CÂncer

COMPOSIÇAO FARMACEUTICA CONTENDO EUPOMATENOIDE-5 EXTRAIDO DE Piper regnellii E SEU USO EM COMPOSIÇÕES MEDICAMENTOSAS DESTINADAS PARA O TRATAMENTO DE CANCER. A presente invenção trata-se de uma composição farmacêutica contendo eupomatenóide-5, seu uso em composições medicamentosas destinadas para o tratamento de câncer e um método de extração da neolignana eupomatenóide-5 de Piper regnellii (Mig). C. DC. var. regnellii. A composição farmacêutica compreende extrato bruto de Piper regnellii com pelo menos 13% de eupomatenáide-5. A neolignana eupomatenóide-5 foi identificada como um dos principais compostos envolvidos na atividade anticâncer, sem apresentar sinais de toxicidade, com baixa citoxicidade em algumas linhagens tumorais e redução significativa dos volumes dos tumores, sendo diferenciais em se tratando do desenvolvimento de um medicamento guimioterápico.BRPI1003682 (A2)BR2010PI0368

Effects of Myristicin in Association with Chemotherapies on the Reversal of the Multidrug Resistance (MDR) Mechanism in Cancer

A range of drugs used in cancer treatment comes from natural sources. However, chemotherapy has been facing a major challenge related to multidrug resistance (MDR), a mechanism that results in a decrease in the intracellular concentration of chemotherapeutic agents, resulting in reduced treatment efficacy. The protein most frequently related to this effect is P-glycoprotein (P-gp), which is responsible for promoting drug efflux into the extracellular environment. Myristicin is a natural compound isolated from nutmeg and has antiproliferative activity, which has been reported in the literature. The present study aimed to evaluate the effect of the association between myristicin and chemotherapeutic agents on the NCI/ADR-RES ovarian tumor lineage that presents a phenotype of multidrug resistance by overexpression of P-gp. It was observed that myristicin showed no cytotoxic activity for this cell line, since its IC50 was >1 mM. When myristicin was associated with the chemotherapeutic agents cisplatin and docetaxel, it potentiated their cytotoxic effects, a result evidenced by the decrease in their IC50 of 32.88% and 75.46%, respectively. Studies conducted in silico indicated that myristicin is able to bind and block the main protein responsible for MDR, P-glycoprotein. In addition, the molecule fits five of the pharmacokinetic parameters established by Lipinski, indicating good membrane permeability and bioavailability. Our hypothesis is that, by blocking the extrusion of chemotherapeutic agents, it allows these agents to freely enter cells and perform their functions, stopping the cell cycle. Considering the great impasse in the chemotherapeutic treatment of cancer that is the MDR acquired by tumor cells, investigating effective targets to circumvent this resistance remains a major challenge that needs to be addressed. Therefore, this study encourages further investigation of myristicin as a potential reverser of MDR

Antiproliferative effect of Synadenium grantii Hook f. stems (Euphorbiaceae) and a rare phorbol diterpene ester

Synadenium grantii is frequently used for the treatment of various diseases such as allergies, gastric disorders, and especially cancer. The aim of this study was to evaluate the possible antiproliferative potential of the methanol extract, fractions, and pure compounds from the stems of S grantii. Phytochemical analysis was carried out by conventional chromatographic techniques, and the antiproliferative activity was analyzed using the sulforhodamine B assay and an MTT-based assay. Nonpolar fraction and its subfractions from the stems of S grantii exhibited promising cytostatic effect against several human tumor cell lines (glioma, breast, kidney, and lung), with total grown inhibition values ranging from 0.37 to 2.9 μg/mL. One of the active principles of this plant was identified as a rare phorbol diterpene ester, denoted as 3,4,12,13-tetraacetylphorbol-20-phenylacetate. This compound demonstrated antiproliferative activity against glioma, kidney, lung, and triple-negative breast cancer cell lines. These results demonstrate that S grantii stems produce active principles with relevant antiproliferative potential.Peer Reviewe